Status:
COMPLETED
New Therapy for Advanced Stage Leukemia After Stem Cell Transplantation
Lead Sponsor:
Peking University People's Hospital
Conditions:
Leukemia
Eligibility:
All Genders
Up to 60 years
Phase:
NA
Brief Summary
Hematopoietic stem cell transplantation (HSCT) is one of the best, and sometimes the only, option for the treatment of leukemia, particularly for patients with advanced-stage leukemia. However, relaps...
Detailed Description
A G-CSF-primed PBPCI was planned within day 60 post-transplantation before hematologic relapse was diagnosed in patients for which no GVHD occurred or free of GVHD after 2 weeks off immunosuppression ...
Eligibility Criteria
Inclusion
- high-risk leukemia after HSCT
Exclusion
- active GVHD
- early relapse
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2015
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01455272
Start Date
July 1 2009
End Date
March 1 2015
Last Update
April 7 2015
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Lanzhou General Hospital of Lanzhou Command
Lanzhou, Gansu, China
2
Nanfang Hospital, Southern Medical University
Guangzhou, Guangdong, China
3
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
4
The First Affiliated Hospital of Medical School of Zhejiang University
Hangzhou, Zhejiang, China